Skip to main content
    T

    Takeda Pharmaceutical Co Ltd ADR (TAK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $21.59
    +0.16 (+0.77%)

    Market Cap: $68.47B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Takeda Pharmaceutical Co Ltd ADR (TAK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Takeda Pharmaceutical Co Ltd ADR are Teva Pharma Industries Ltd ADR (TEVA), United Therapeutics (UTHR) and Zoetis (ZTS). By market cap, Takeda Pharmaceutical Co Ltd ADR is the largest of the 13 companies on this page, at $68.47B. The median P/E of the 9 companies with a P/E is 18.4x.

    Peer Comparison

    TAK's ROIC of 5.6% is above the peer median of 5.0%, and its revenue growth of 6.7% is below the median of 7.4%. It yields 2.92%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Takeda Pharmaceutical Co Ltd ADR (TAK)$68.47BN/A2.3x0.9%5.6%6.7%2.92%
    Teva Pharma Industries Ltd ADR (TEVA)$51.92B14.4x2.9x2.9%4.3%-1.9%0.00%
    United Therapeutics Corporation (UTHR)$25.18B22.2x7.9x38.6%N/A4.1%0.00%
    Zoetis Inc (ZTS)$34.06B12.7x3.7x26.4%21.7%-1.3%2.51%
    Haleon plc (HLN)$40.25BN/A1.6x14.5%13.9%2.2%2.12%
    Viatris Inc (VTRS)$23.87B8.1x1.6x-4.1%-0.2%-0.3%2.31%
    Dr. Reddy’s Laboratories Ltd ADR (RDY)$12.29B39.6x3.5x8.5%5.7%-1.5%0.44%
    Neurocrine Biosciences Inc (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Alpha Teknova Inc (TKNO)$516.43MN/A9.1x-34.8%-20.5%21.5%0.00%
    Kamada (KMDA)$467.05M18.9x2.4x12.7%N/A10.7%2.10%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Peer median$14.62B18.4x3.2x13.0%5.0%7.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Takeda Pharmaceutical Co Ltd ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Teva Pharma Industries Ltd ADR (TEVA)
    Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs...
    TEVA competitors
    United Therapeutics Corporation (UTHR)
    United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs...
    UTHR competitors
    Zoetis Inc (ZTS)
    Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
    ZTS competitors
    Haleon plc (HLN)
    Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline...
    Viatris Inc (VTRS)
    Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
    VTRS competitors
    Dr. Reddy’s Laboratories Ltd ADR (RDY)
    Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
    RDY competitors
    Neurocrine Biosciences Inc (NBIX)
    Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological...
    NBIX competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Alpha Teknova Inc (TKNO)
    Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements...
    TKNO competitors
    Kamada (KMDA)
    Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
    KMDA competitors
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Tilray Inc (TLRY)
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors

    Frequently Asked Questions About TAK

    Who are Takeda Pharmaceutical Co Ltd ADR's main competitors?

    The companies most similar to Takeda Pharmaceutical Co Ltd ADR include Teva Pharma Industries Ltd ADR (TEVA), United Therapeutics (UTHR), Zoetis (ZTS), Haleon (HLN) and Viatris (VTRS), listed from the closest match.

    Who is Takeda Pharmaceutical Co Ltd ADR's biggest competitor?

    Teva Pharma Industries Ltd ADR (TEVA) is both the largest of the similar companies at $51.92B and the closest match by business profile, size, sector and industry.

    How does TAK stock compare with its competitors?

    TAK's P/S is 2.3x against a peer median of 3.2x; its net margin is 0.9% against a peer median of 13.0%.

    Which of Takeda Pharmaceutical Co Ltd ADR's competitors pays a higher dividend?

    Takeda Pharmaceutical Co Ltd ADR has a forward dividend yield of 2.92%. None of the similar companies with available yields has a higher forward dividend yield.

    Is Takeda Pharmaceutical Co Ltd ADR bigger than its competitors?

    Yes. Takeda Pharmaceutical Co Ltd ADR is the largest by market cap among the 13 companies on this page, at $68.47B.